小分子和化合物库

选项
视图 列表 网格

显示第112个,产品总数64

设置降序方向
  1. TW-37,小分子BCL-2抑制剂
      规格或纯度 :
    • ≥98%
    CAS号 : 877877-35-5        Compound CID : 11455910
    分子式: C33H35NO6S        分子量: 573.71
    IUPAC Name: N-[4-(2-tert-butylphenyl)sulfonylphenyl]-2,3,4-trihydroxy-5-[(2-propan-2-ylphenyl)methyl]benzamide
    SMILES: CC(C)C1=CC=CC=C1CC2=CC(=C(C(=C2O)O)O)C(=O)NC3=CC=C(C=C3)S(=O)(=O)C4=CC=CC=C4C(C)(C)C
    InChIKey: PQAPVTKIEGUPRN-UHFFFAOYSA-N
    InChI: InChI=1S/C33H35NO6S/c1-20(2)25-11-7-6-10-21(25)18-22-19-26(30(36)31(37)29(22)35)32(38)34-23-14-16-24(17-15-23)41(39,40)28-13-9-8-12-27(28)33(3,4)5/h6-17,19-20,35-37H,18H2,1-5H3,(H,34,38)
  2. LDN-193189,BMP I 型受体抑制剂
      规格或纯度 :
    • ≥98%
    CAS号 : 1062368-24-4        Compound CID : 25195294
    分子式: C25H22N6        分子量: 479.4
    IUPAC Name: 4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline
    SMILES: C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3
    InChIKey: CDOVNWNANFFLFJ-UHFFFAOYSA-N
    InChI: InChI=1S/C25H22N6/c1-2-4-24-22(3-1)21(9-10-27-24)23-16-29-31-17-19(15-28-25(23)31)18-5-7-20(8-6-18)30-13-11-26-12-14-30/h1-10,15-17,26H,11-14H2
  3. A-1155463,BCL-XL抑制剂
      规格或纯度 :
    • ≥97%
    CAS号 : 1235034-55-5        Compound CID : 59447577
    分子式: C35H32FN5O4S2        分子量: 669.79
    IUPAC Name: 2-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-5-[3-[4-[3-(dimethylamino)prop-1-ynyl]-2-fluorophenoxy]propyl]-1,3-thiazole-4-carboxylic acid
    SMILES: CN(C)CC#CC1=CC(=C(C=C1)OCCCC2=C(N=C(S2)N3CCC4=C(C3)C(=CC=C4)C(=O)NC5=NC6=CC=CC=C6S5)C(=O)O)F
    InChIKey: SOYCFODXNRVBTI-UHFFFAOYSA-N
    InChI: InChI=1S/C35H32FN5O4S2/c1-40(2)17-6-8-22-14-15-28(26(36)20-22)45-19-7-13-30-31(33(43)44)38-35(47-30)41-18-16-23-9-5-10-24(25(23)21-41)32(42)39-34-37-27-11-3-4-12-29(27)46-34/h3-5,9-12,14-15,20H,7,13,16-19,21H2,1-2H3,(H,43,44)(H,37,39,42)
  4. ABT-263,小分子Bcl-2家族蛋白抑制剂
      规格或纯度 :
    • ≥98%
    CAS号 : 923564-51-6        Compound CID : 24978538
    分子式: C47H55ClF3N5O6S3        分子量: 974.61
    IUPAC Name: 4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide
    SMILES: CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)NC(CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C
    InChIKey: JLYAXFNOILIKPP-KXQOOQHDSA-N
    InChI: InChI=1S/C47H55ClF3N5O6S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-55-22-24-56(25-23-55)39-14-10-35(11-15-39)45(57)53-65(60,61)41-16-17-43(44(30-41)64(58,59)47(49,50)51)52-38(19-21-54-26-28-62-29-27-54)33-63-40-6-4-3-5-7-40/h3-17,30,38,52H,18-29,31-33H2,1-2H3,(H,53,57)/t38-/m1/s1
  5. DMH-1,BMP-1受体抑制剂
      规格或纯度 :
    • ≥98%
    CAS号 : 1206711-16-1        Compound CID : 50997747
    分子式: C24H20N4O        分子量: 380.44
    IUPAC Name: 4-[6-(4-propan-2-yloxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline
    SMILES: CC(C)OC1=CC=C(C=C1)C2=CN3C(=C(C=N3)C4=CC=NC5=CC=CC=C45)N=C2
    InChIKey: JMIFGARJSWXZSH-UHFFFAOYSA-N
    InChI: InChI=1S/C24H20N4O/c1-16(2)29-19-9-7-17(8-10-19)18-13-26-24-22(14-27-28(24)15-18)20-11-12-25-23-6-4-3-5-21(20)23/h3-16H,1-2H3
  6. LDN 212854,I型强骨形态发生蛋白(ALK)抑制剂
      规格或纯度 :
    • ≥98%(HPLC)
    CAS号 : 1432597-26-6        Compound CID : 60182388
    分子式: C25H22N6        分子量: 406.48
    IUPAC Name: 5-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline
    SMILES: C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=C6C=CC=NC6=CC=C5)N=C3
    InChIKey: BBDGBGOVJPEFBT-UHFFFAOYSA-N
    InChI: InChI=1S/C25H22N6/c1-3-21(22-4-2-10-27-24(22)5-1)23-16-29-31-17-19(15-28-25(23)31)18-6-8-20(9-7-18)30-13-11-26-12-14-30/h1-10,15-17,26H,11-14H2
  7. Navitoclax (ABT-263)
      规格或纯度 :
    • 10mM in DMSO
    CAS号 : 923564-51-6(DMSO)       
    分子式: C47H55ClF3N5O6S3        分子量: 974.61
    SMILES: CC1(C)CCC(=C(CN2CCN(CC2)C3=CC=C(C=C3)C(=O)N[S](=O)(=O)C4=CC(=C(NC(CCN5CCOCC5)CSC6=CC=CC=C6)C=C4)[S](=O)(=O)C(F)(F)F)C1)C7=CC=C(Cl)C=C7
每页